Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: Phase III Prospective Randomized Comparison of Depot Octreotide plus Interferon Alpha versus Depot Octreotide plus Bevacizumab (NSC #704865) in Advanced; Poor Prognosis Carcinoid PatientsCIRB: Adult CIRB - Late Phase EmphasisLead Group: SWOGStatus: CompletedReview Status: Completed
